Purmorphamine and oxysterols accelerate and promote osteogenic differentiation of mesenchymal stem cells in vitro

In Vivo

Volumn 29, Issue 2, 2015, Pages 247-254

  Wöltje, Michael ^a   Böbel, Melanie ^b   Heiland, Max ^c   Beck Broichsitter, Benedicta ^c   Al Dam, Ahmad ^c   Gröbe, Alexander ^c   Friedrich, Reinhard E ^c   Hanken, Henning ^c   Smeets, Ralf ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Spintec Engineering GmbH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

In vitro; Mesenchymal stem cells; Osteogenic differentiation; Oxysterols; Purmorphamine; Tissue engineering

Indexed keywords

22 HYDROXYCHOLESTEROL; ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; FLUINDOSTATIN; GROWTH PROMOTOR; HYDROXYCHOLESTEROL; MEVINOLIN; OSTEOCALCIN; OSTEOPONTIN; OXYSTEROL; PURMORPHAMINE; UNCLASSIFIED DRUG; MORPHOLINE DERIVATIVE; PURINE DERIVATIVE; STEROID;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEDIMENTATION; TISSUE ENGINEERING; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; TIME;

ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; MESENCHYMAL STROMAL CELLS; MORPHOLINES; OSTEOGENESIS; PURINES; RATS; STEROIDS; TIME FACTORS;

EID: 84928121178     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Taylor GI, Miller GD and Ham FJ: The free vascularized bone graft. A clinical extension of microvascular techniques. Plast Reconstr Surg 55(5): 533-544, 1975.
2. Riediger D: Restoration of masticatory function by microsurgically revascularized iliac crest bone grafts using enosseous implants. Plast Reconstr Surg 81(6): 861-877, 1988.
3. Papadopulos NA, Schaff J, Sader R, Kovacs L, Deppe H, Kolk A and Biemer E: Mandibular reconstruction with free osteofasciocutaneous fibula flap: a 10 years experience. Injury 39(Suppl 3): S75-82, 2008.
4. Hipp J and Atala A: Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod 1(1): 3, 2004.
5. Nash KL and Gimson AE: Liver transplantation. Hosp Med 64(4): 200-204, 2003.
6. Stockmann P, Park J, von Wilmowsky C, Nkenke E, Felszeghy E, Dehner JF, Schmitt C, Tudor C and Schlegel KA: Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources. Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-Maxillo- Facial Surgery 40(4): 310-320, 2012.
7. Korn P, Schulz MC, Range U, Lauer G and Pradel W: Efficacy of tissue engineered bone grafts containing mesenchymal stromal cells for cleft alveolar osteoplasty in a rat model. Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014 (In Press).
8. Hausamen JE and Neukam FW: [Transplantation of bones]. Eur Arch Otorhinolaryngol Suppl 1: 163-177, 1992.
9. Schliephake H, Schmelzeisen R, Maschek H and Haese M: Long-term results of the use of silicone sheets after diskectomy in the temporomandibular joint: clinical, radiographic and histopathologic findings. Int J Oral Maxillofac Surg 28(5): 323-329, 1999.
10. Schliephake H, Schmelzeisen R, Samii M and Sollmann WP: Microvascular reconstruction of the skull base: indications and procedures. J Oral Maxillofac Surg 57(3): 233-239, 1999.
11. Awad HA, Butler DL, Harris MT, Ibrahim RE, Wu Y, Young RG, Kadiyala S and Boivin GP: In vitro characterization of mesenchymal stem cell-seeded collagen scaffolds for tendon repair: effects of initial seeding density on contraction kinetics. J Biomed Mater Res 51(2): 233-240, 2000.
12. Radice M, Brun P, Cortivo R, Scapinelli R, Battaliard C and Abatangelo G: Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res 50(2): 101-109, 2000.
13. Petite H, Viateau V, Bensaid W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L and Guillemin G: Tissue-engineered bone regeneration. Nat Biotechnol 18(9): 959-963, 2000.
14. Ponticiello MS, Schinagl RM, Kadiyala S and Barry FP: Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 52(2): 246-255, 2000.
15. Alhadlaq A and Mao JJ: Tissue-engineered neogenesis of human-shaped mandibular condyle from rat mesenchymal stem cells. J Dent Res 82(12): 951-956, 2003.
16. Jaiswal N, Haynesworth SE, Caplan AI and Bruder SP: Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64(2): 295-312, 1997.
17. Oda T, Notoya K, Gotoh M, Taketomi S, Fujisawa Y, Makino H and Sohda T: Synthesis of novel 2-benzothiopyran and 3-benzothiepin derivatives and their stimulatory effect on bone formation. J Med Chem 42(4): 751-760, 1999.
18. Wu X, Ding S, Ding Q, Gray NS and Schultz PG: A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J Am Chem Soc 124(49): 14520-14521, 2002.
19. Beloti MM, Bellesini LS and Rosa AL: Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells. Cell Biol Int 29(7): 537-541, 2005.
20. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M and Gutierrez G: Stimulation of bone formation in vitro and in rodents by statins. Science 286(5446): 1946-1949, 1999.
21. Maeda T, Matsunuma A, Kawane T and Horiuchi N: Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 280(3): 874-877, 2001.
22. Edwards CJ and Spector TD: Statins as modulators of bone formation. Arthritis research 4(3): 151-153, 2002.
23. Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ and Parhami F: Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J Bone Miner Res 19(5): 830-840, 2004.
24. Dwyer JR, Sever N, Carlson M, Nelson SF, Beachy PA and Parhami F: Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J Biol Chem 282(12): 8959-8968, 2007.
25. Friedenstein AJ, Gorskaja JF and Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4(5): 267-274, 1976.
26. Gregory CA, Gunn WG, Peister A and Prockop DJ: An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329(1): 77-84, 2004.
27. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB and Stein GS: Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143(3): 420-430, 1990.
28. Cheng SL, Yang JW, Rifas L, Zhang SF and Avioli LV: Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134(1): 277-286, 1994.
29. Ohnaka K, Taniguchi H, Kawate H, Nawata H and Takayanagi R: Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 318(1): 259-264, 2004.
30. Devogelaer JP: Glucocorticoid-induced osteoporosis: mechanisms and therapeutic approach. Rheum Dis Clin North Am 32(4): 733-757, 2006.
31. Lukert BP: Glucocorticoid-induced bone loss: a neglected problem. Chest 105(6): 1640-1641, 1994.
32. Weinstein RS, Jilka RL, Parfitt AM and Manolagas SC: Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102(2): 274-282, 1998.
33. Gellynck K, Shah R, Parkar M, Young A, Buxton P and Brett P: Small molecule stimulation enhances bone regeneration but not titanium implant osseointegration. Bone 57(2): 405-412, 2013.
34. Oliveira FS, Bellesini LS, Defino HL, da Silva Herrero CF, Beloti MM and Rosa AL: Hedgehog signaling and osteoblast gene expression are regulated by purmorphamine in human mesenchymal stem cells. J Cell Biochem 113(1): 204-208, 2012.
35. Faghihi F, Baghaban Eslaminejad M, Nekookar A, Najar M and Salekdeh GH: The effect of purmorphamine and sirolimus on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Biomed Pharmacother 67(1): 31-38, 2013.
36. Kim WK, Meliton V, Tetradis S, Weinmaster G, Hahn TJ, Carlson M, Nelson SF and Parhami F: Osteogenic oxysterol, 20(S)-hydroxycholesterol, induces notch target gene expression in bone marrow stromal cells. J Bone Miner Res 25(4): 782-795, 2010.